Literature DB >> 28103445

Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologists.

Yolanda D Tseng1, Smith Apisarnthanarax1, Jay J Liao1, Shailender Bhatia1, Paul T Nghiem1, Upendra Parvathaneni1.   

Abstract

BACKGROUND: It is unclear which subgroups of Merkel cell carcinoma (MCC) patients benefit the most from radiation. We surveyed radiation oncologists (RO) that regularly see and treat MCC to understand how they approach the treatment of early-stage MCC.
METHODS: A web-based survey was emailed to 63 ROs, who were identified through publications, guideline panel membership, and/or affiliation with institutions of high MCC volume. ROs provided treatment recommendations for two hypothetical case scenarios of early stage MCC.
RESULTS: Among 28 respondents (45%), 26 regularly saw and treated MCC patients for a median 7 years (range, 0-30). While all ROs recommended adjuvant radiation for a stage II upper extremity MCC, only 48% recommended adjuvant radiation for stage I head and neck MCC.
CONCLUSION: Among US-based MCC RO 'specialists,' there is equipoise on the role of radiotherapy for stage I MCC. Ideally, prospective studies are needed to identify which patients may benefit from radiation.

Entities:  

Keywords:  Merkel cell carcinoma; adjuvant treatment; early stage; radiation; surgery

Mesh:

Year:  2017        PMID: 28103445     DOI: 10.1080/14737140.2017.1285233

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  1 in total

1.  Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck.

Authors:  Maclean M Cook; Stephanie K Schaub; Peter H Goff; Alex Fu; Song Y Park; Daniel S Hippe; Jay J Liao; Smith Apisarnthanarax; Shailender Bhatia; Yolanda D Tseng; Paul T Nghiem; Upendra Parvathaneni
Journal:  Adv Radiat Oncol       Date:  2020-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.